Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biocon Chief Says No Chance For Indian Firm In M&A

This article was originally published in PharmAsia News

Executive Summary

The head of India's Biocon biotechnology company says she does not anticipate ever selling her company. Kiran Mazumdar Shaw, chairman and managing director of the firm, said her emotional attachment to the company is too strong for her to consider selling out to another firm, as Ranbaxy Laboratories is doing. She said her loyalty and desire to expand the company probably result from her being a first-generation entrepreneur. It is often the following generations without an emotional attachment to a start-up that are willing to consider mergers and acquisitions, she said. She acknowledged, however, the state of flux in the biotechnology sector presents its own challenge to companies. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts